TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Glancy Prongay & Murray Llp
Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Telix Pharmaceuticals faces potential securities fraud lawsuit after stock price drops following SEC subpoena and FDA Complete Response Letter regarding prostate cancer therapeutic candidates.

Insights
UONEK   negative

Consolidated net revenue declined 16%, adjusted EBITDA dropped 44.1%, digital segment profitability decreased significantly, and full-year EBITDA guidance was lowered from $60 million to $56-$58 million


TLX   negative

Company received SEC subpoena and FDA Complete Response Letter, leading to significant stock price declines of 10.4% and 16.1% on two separate occasions, suggesting potential regulatory and developmental challenges with their prostate cancer therapeutic candidates